Home
Conditions
Dendritic Cell Sarcoma, Interdigitating

Clinical trial condition

Dendritic Cell Sarcoma, Interdigitating

Explore clinical trials studying Dendritic Cell Sarcoma, Interdigitating. Study availability and eligibility vary by location and protocol.

228 public trials 29 recruiting studies

Refine in advanced search Browse all conditions

Dendritic Cell Sarcoma, Interdigitating trial results

Recruiting

Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma

NCT06220032

Conditions: Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +22 more
Locations: NL-Den Bosch-JBZ 's-Hertogenbosch, Netherlands

NL-Almelo-ZGTALMELO Almelo, Netherlands

NL-Amstelveen-AMSTELLAND Amstelveen, Netherlands

NL-Apeldoorn-GELREAPELDOORN Apeldoorn, Netherlands

View all 25 locations

View Trial Details

Recruiting

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

NCT06736613

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma, +21 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States

View Trial Details

Recruiting

Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta

NCT05950802

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Recruiting

Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL

NCT07255963

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

Q702 for the Treatment of Patients With Hematologic Malignancies

NCT06712810

Conditions: Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, Bone Marrow Diseases, +87 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

NCT05940272

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +15 more
Locations: Memorial Sloan Kettering Cancer Center (All protocol activities) New York, United States

NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only) New York, United States

View Trial Details

Recruiting

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

NCT05857969

Conditions: Bone Marrow Diseases, Chronic Disease, Dendritic Cell Sarcoma, Interdigitating, +38 more
Locations: Nicklaus Children's Hospital Miami, Florida, United States

View Trial Details

Recruiting

Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL

NCT07057765

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
Locations: Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University Cairo, Cairo Governorate, Egypt

View Trial Details

Recruiting

Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma

NCT06830031

Conditions: DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-cell-lymphoma, +22 more
Locations: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Recruiting

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

NCT05377307

Conditions: Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3A, +16 more
Locations: Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung, Taiwan

National Taiwan University Hospital Taipei, Taiwan

Taipei Veterans General Hospital Taipei, Taiwan

Chi Mei Medical Center Tainan, Taiwan

View Trial Details

Dendritic Cell Sarcoma, Interdigitating

Dendritic Cell Sarcoma, Interdigitating trial results

Related conditions